The Nurse View: Targeted Therapies for the Patient With Metastatic

Colorectal Cancer

Targeted Therapies Used in the Treatment of Patients With

mCRC

Case 1: 70-year-old Man With Inoperable mCRC (cont)

Ziv-aflibercept: Potential Side Effects

Ziv-aflibercept: Monitoring for Side Effects

Case 2: 47-year-old Woman With Disease Recurrence Following an Initial Diagnosis of

Stage IIIC Colon Cancer

Regorafenib: Key Patient Education Issues

Regorafinib: Potential Side Effects

Case 2: 47-year-old Woman With mCRC Receiving

Regorafenib

Regorafinib: Monitoring for Side Effects

Hand-Foot Skin Reaction

Strategies for Combating Fatigue

The Importance of Patient Education

Strategies for Prevention and Treatment of HFSR

Hand-Foot Skin Reaction (cont)

Hand-Foot Syndrome vs Hand-Foot Skin Reaction

Summary: Strategies for Optimizing Use of New Targeted

Agents in mCRC

Abbreviations

References

References (cont)

References (cont)